Resmed Inc
Research Resmed Inc (RMD) on Bullrun: valuation model: 11.8% undervalued, market cap USD 33.84B, P/E 22.5, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRMD
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal11.8% undervalued
- Market capUSD 33.84B
- P/E22.5
- Dividend yield1.1%
- Financial periodFY2026
- RevenueUSD 5.65B
- Revenue growth9.9%
- Net incomeUSD 1.52B
- Free cash flowUSD 1.63B
- Gross margin61.1%
Valuation Snapshot
Bullrun's latest valuation model marks Resmed Inc as 11.8% undervalued; latest market cap is USD 33.84B; P/E is 22.5; dividend yield is 1.1%.
Peer valuation comparison
Latest P/E is 22.48x versus a Healthcare sector median of 24.6x (8.6% below).
Latest dividend yield is 1.05% versus a Healthcare sector median of 1.84% (42.9% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 5.65B | USD 1.52B | USD 1.63B | 61.1% | n/a | USD 1.47B | USD 825.92M | USD 6.59B |
| FY2025 | USD 5.15B | USD 1.40B | USD 1.66B | 59.4% | 9.51 | USD 1.21B | USD 668.29M | USD 5.97B |
| FY2024 | USD 4.69B | USD 1.02B | USD 1.30B | 56.7% | 6.92 | USD 238.36M | USD 707.21M | USD 4.86B |
| FY2023 | USD 4.22B | USD 897.56M | USD 573.63M | 55.8% | 6.09 | USD 227.89M | USD 1.44B | USD 4.13B |
| FY2022 | USD 3.58B | USD 779.44M | USD 216.31M | 56.6% | 5.3 | USD 273.71M | USD 775.24M | USD 3.36B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 33.84B | 22.5 | 1.0% | 2.46 |
| 2025 | 2025-12-31 | USD 35.09B | 23.8 | 0.9% | 2.26 |
| 2024 | 2024-12-31 | USD 33.58B | 27.0 | 0.9% | 2.02 |
| 2023 | 2023-12-29 | USD 25.30B | 28.0 | 1.1% | 1.84 |
| 2022 | 2022-12-30 | USD 30.49B | 38.9 | 0.8% | 1.72 |
| 2021 | 2021-12-31 | USD 38.09B | 73.4 | 0.6% | 1.62 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.46 USD, yield 1.1%.
| Year | Dividends/share |
|---|---|
| FY2026 | 1.86 USD |
| FY2025 | 2.12 USD |
| FY2024 | 1.92 USD |
| FY2023 | 1.76 USD |
| FY2022 | 1.68 USD |
About Resmed Inc
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring;
ETFs that hold Resmed Inc
Resmed Inc is one of the ten largest holdings of 4 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| iShares US Medical Devices UCITS ETF USD (Acc) | 3.31% | 0.25% |
| First Trust Capital Strength UCITS ETF Class A USD Accumulation | 2.29% | 0.60% |
| Fidelity Digital Health UCITS ETF USD Acc | 4.32% | 0.50% |
| First Trust Growth Strength UCITS ETF Class A USD Accumulation | 2.31% | 0.60% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Resmed Inc overvalued or undervalued?
Bullrun's valuation model currently marks Resmed Inc as 11.8% undervalued.
What is Resmed Inc's market cap?
Resmed Inc's market capitalization is USD 33.84B.
What is Resmed Inc's P/E ratio?
Resmed Inc's price-to-earnings (P/E) ratio is 22.5.
Does Resmed Inc pay a dividend?
Resmed Inc has a dividend yield of 1.1%.
What does Resmed Inc do?
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.